Novartis AG/Fr. NOVN
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Novartis AG
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, Switzerland. It operates primarily in the healthcare industry, focusing on the research, development, and manufacturing of a wide range of prescription medications targeting oncology, immunology, neuroscience, and cardiovascular diseases. Key products include Cosentyx (for psoriasis and arthritis) and Entresto (for heart failure). Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has a significant geographic presence, with operations in over 100 countries. A key competitive strength of the company is its strong investment in research and development, which underpins its substantial portfolio of innovative therapies.
Ticker
Fr. NOVN
Sector
Primary listing
XSWX
Employees
75,267
Headquarters
Basel, Switzerland
Website
Novartis AG Metrics
BasicAdvanced
CHF 244bn
23.83
CHF 5.42
0.49
CHF 3.70
2.86%
Price and volume
Market cap
CHF 244bn
Beta
0.49
52-week high
CHF 131.00
52-week low
CHF 91.56
Average daily volume
2.8m
Dividend rate
CHF 3.70
Financial strength
Current ratio
0.862
Quick ratio
0.55
Long term debt to equity
93.339
Total debt to equity
116.85
Dividend payout ratio (TTM)
71.08%
Interest coverage (TTM)
13.36%
Profitability
EBITDA (TTM)
18,929.504
Gross margin (TTM)
74.98%
Net profit margin (TTM)
22.50%
Operating margin (TTM)
32.75%
Effective tax rate (TTM)
17.88%
Revenue per employee (TTM)
CHF 614,640
Management effectiveness
Return on assets (TTM)
10.25%
Return on equity (TTM)
30.35%
Valuation
Price to earnings (TTM)
23.83
Price to revenue (TTM)
5.319
Price to book
5.88
Price to tangible book (TTM)
-8.95
Price to free cash flow (TTM)
19.911
Free cash flow yield (TTM)
5.02%
Free cash flow per share (TTM)
6.488
Dividend yield (TTM)
2.86%
Forward dividend yield
2.86%
Growth
Revenue change (TTM)
2.73%
Earnings per share change (TTM)
-3.43%
3-year revenue growth (CAGR)
8.37%
10-year revenue growth (CAGR)
1.32%
3-year earnings per share growth (CAGR)
22.59%
10-year earnings per share growth (CAGR)
8.97%
3-year dividend per share growth (CAGR)
10.48%
10-year dividend per share growth (CAGR)
5.64%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.